These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 15340889
1. [Performance of carriers and non-carriers of the E280A mutation for familial Alzheimer's disease in a naming test]. Tirado V, Muñoz C, Aguirre C, Pineda DA, Lopera F. Rev Neurol; ; 39(4):322-6. PubMed ID: 15340889 [Abstract] [Full Text] [Related]
2. [Analysis of intrusive errors in a memory test as possible pre-clinical marker of familial Alzheimer disease, in E280A presenilin-1 mutation carrier]. Tirado V, Motta M, Aguirre-Acevedo DC, Pineda DA, Lopera F. Rev Neurol; ; 47(6):290-4. PubMed ID: 18803154 [Abstract] [Full Text] [Related]
8. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy. Velez-Pardo C, Arellano JI, Cardona-Gomez P, Jimenez Del Rio M, Lopera F, De Felipe J. Epilepsia; 2004 Jul; 45(7):751-6. PubMed ID: 15230697 [Abstract] [Full Text] [Related]
12. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption? Balthazar ML, Cendes F, Damasceno BP. Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343 [Abstract] [Full Text] [Related]
13. Linguistic changes in verbal expression: a preclinical marker of Alzheimer's disease. Cuetos F, Arango-Lasprilla JC, Uribe C, Valencia C, Lopera F. J Int Neuropsychol Soc; 2007 May; 13(3):433-9. PubMed ID: 17445292 [Abstract] [Full Text] [Related]
14. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study. Acosta-Baena N, Sepulveda-Falla D, Lopera-Gómez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, Saldarriaga A, Lopera F. Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022 [Abstract] [Full Text] [Related]
16. Cognitive impairment in Alzheimer's disease is modified by APOE genotype. van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM. Dement Geriatr Cogn Disord; 2007 Mar; 24(2):98-103. PubMed ID: 17596691 [Abstract] [Full Text] [Related]
18. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers. Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta-Baena N, Madrigal L, Muñoz C, Tirado V, Moreno S, Tariot PN, Lopera F, Reiman EM. J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373 [Abstract] [Full Text] [Related]
19. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene. Aguirre-Acevedo DC, Jaimes-Barragán F, Henao E, Tirado V, Muñoz C, Reiman EM, Tariot PN, Langbaum JB, Lopera F. Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578 [Abstract] [Full Text] [Related]
20. [Language and cognitive impairment: a semiological study into visual naming]. Fernández-Turrado T, Tejero-Juste C, Santos-Lasaosa S, Pérez-Lázaro C, Piñol-Ripoll G, Mostacero-Miguel E, Pascual-Millán LF. Rev Neurol; 2016 Mar; 42(10):578-83. PubMed ID: 16703524 [Abstract] [Full Text] [Related] Page: [Next] [New Search]